348 results on '"Arsov C"'
Search Results
102. Prävalenz der erektilen Dysfunktion bei 45-jährigen Männern in Abhängigkeit von vorhandenen Risikofaktoren
103. PT095 - How to prevent patients with a false positive overall score of PI-RADS 4
104. 1134 - Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
105. 468 - Multiparametric MRI can exclude prostate cancer progression in patients under active surveillance
106. Gezielte MRT-gestützte Biopsie der Prostata: Ist mehr als ein Biopsiezylinder pro MRT-Läsion erforderlich?
107. 89 The association between family history and prostate-specific antigen from a large group of 45-year old men embarking on prostate cancer screening: Results from the PROBASE trial
108. 490 - Multiparametric-MRI/ultrasound fusion prostate biopsy: Are two biopsy cores per MRI-lesion required?
109. 267 - The German risk-adapted Prostate Cancer Screening Trial (PROBASE): First results after recruitment of 30.000 men
110. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.
111. Risikoreduktion eines Gleason-Upgrades bei der radikalen Prostatektomie durch gezielte MRT-Biopsieverfahren
112. Prospektiv randomisierter Vergleich der MRT-(in-bore)-Biopsie mit der Kombination aus MRT/Ultraschall-Fusions- und klassischer TRUS-Biopsie zur Prostatakarzinomdiagnostik bei zuvor negativer Biopsie
113. MRT-(in-bore)-Prostatabiopsie als Goldstandard der gezielten Biopsiemethoden?
114. 321 European multi-centre study to assess the aggressiveness of prostate adenocarcinoma in newly-diagnosed patients using a cell-cycle gene expression assay (Prolaris™) in biopsy specimens (EMPATHY-P Study)
115. 23 The German risk-adapted PCA Screening Trial (PROBASE) – first results
116. 761 A prospective randomized study comparing MR-guided in-bore versus MRI/ultrasound fusionguided prostate biopsy in patients with prior tumor-negative TRUS biopsy
117. 214 The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy
118. EGFR peptide-specific T cells in head and neck squamous cell carcinoma
119. 247 - A positive digital rectal examination (DRE) does not predict prostate cancer in 45 yr old men - results from the German risk-adapted PCA Screening Trial (PROBASE)
120. T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx
121. Stellenwert der MRT-Sequenzen mittels PI-RADS Score hinsichtlich Detektion von Prostatakarzinomen auf der Basis gezielter MR-Biopsien
122. Korrelation des PI-RADS Summenscore mit dem Gleason score von gezielt MR bioptisch gesicherten Prostatakarzinomen
123. Tumordetektion und Vorhersagequalität des PI-RADS Summenscores für Prostatakarzinome anhand gezielter MRT-Biopsien
124. 1057 Correlation of the PI-RADS score and the Gleason grade in prostate cancer lesions after targeted in bore MR-biopsy
125. 948 Comparison of targeted in-bore MRI–guided biopsy and conventional transrectal ultrasound (TRUS) – guided biopsy in biopsy-naïve patients with elevated prostate specific antigen (PSA) level
126. EGFR-spezifische T-Zellen im Plattenepithelkarzinom des Kopf-Hals-Bereiches
127. PSA-gestützte Früherkennung
128. Interobserver-Reliabilität des ESUR-Scoringsystems (PI-RADS) und Vergleich mit einem alternativen Scoringsystem mittels MRT-biopsierter Läsionen
129. Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients
130. Inter-Reader Agreement of Multi-Parametric MR Imaging for the Detection of Prostate Cancer: Evaluation of a Scoring System
131. Interobserver-Reliabilität beim funktionellen Prostata MRT: Evaluation eines Scoringsystems
132. MRT-gesteuerte Prostatabiopsie bei 3 Tesla - erste Ergebnisse
133. Evaluation of a Structured Report of Functional Prostate Magnetic Resonance Imaging in Patients with Suspicion for Prostate Cancer or under Active Surveillance
134. Statistische Evaluation der Diffusionsbildgebung der Prostata bei 3-TESLA
135. V12 EXTRAPERITONEAL LAPARO-ENDOSCOPIC SINGLE SITE RADICAL PROSTATECTOMY (LESS)
136. Value of galvanotherapy for localised prostate cancer
137. Prostatakarzinomzentren / Prostatazentren – Zertifiziert von DKG oder DVPZ
138. Risikovorhersage positiver Schnittränder bei radikaler Prostatektomie mittels präoperativer MRT.
139. Epitope des Humanen Papilloma Virus (HPV) Typ 16 als Zielstruktur einer T-Zell-Immunantwort gegen Oropharynx-karzinome
140. Inter-Reader Agreement of Multi-Parametric MR Imaging for the Detection of Prostate Cancer: Evaluation of a Scoring System.
141. Prostatakarzinomzentren / Prostatazentren – Zertifiziert von DKG oder DVPZ.
142. Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
143. A0815 - MRI-guided active surveillance without re-biopsy in patients with ISUP 1 and 2 prostate cancer – results of radical prostatectomy and mid-term follow up of the prospective PROMM-AS study.
144. Effekt eines einmalig durchgeführten PSA-Screenings : Die CAP-Studie.
145. MRI grading for the prediction of prostate cancer aggressiveness.
146. Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging.
147. A0960 - MRI-guided Active Surveillance without annual re-biopsy in patients with ISUP 1 and 2 prostate cancer – The prospective PROMM-AS Study.
148. Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy.
149. P239 - Worry about prostate cancer and risk perception among middle-aged men: Results from the PROBASE trial.
150. Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.